Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 75 articles:
HTML format
Text format



Single Articles


    September 2017
  1. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  2. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  3. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  4. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  5. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  6. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  7. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  8. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  9. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  10. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  11. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  12. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  13. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  14. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  15. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  16. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  17. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  18. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  19. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  20. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  21. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  22. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  23. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  24. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available


    December 2016
  25. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  26. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  27. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  28. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  29. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available



  30. Committee Opinion No 672: Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:e69-77.
    PubMed     Text format     Abstract available



  31. Committee Opinion No 672 Summary Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:674-5.
    PubMed     Text format     Abstract available


    August 2016

  32. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:e32-7.
    PubMed     Text format     Abstract available



  33. Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:422-3.
    PubMed     Text format     Abstract available



  34. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  35. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  36. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    June 2016
  37. RODRIGUEZ MI, Anderson L, Edelman AB
    Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  38. STUART GS
    What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  39. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  40. SIMMONS K, Edelman A, Fu R, Jensen J, et al
    A Short Course of Tamoxifen Reduces Unscheduled Bleeding in Etonogestrel Contraceptive Implant Users [24].
    Obstet Gynecol. 2016;127 Suppl 1:9S.
    PubMed     Text format     Abstract available


    February 2016
  41. GALLO MF, Legardy-Williams J, Hylton-Kong T, Rattray C, et al
    Association of Progestin Contraceptive Implant and Weight Gain.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  42. BOOZALIS A, Tutlam NT, Chrisman Robbins C, Peipert JF, et al
    Sexual Desire and Hormonal Contraception.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  43. POTTER JE, Hubert C, Stevenson AJ, Hopkins K, et al
    Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.
    Obstet Gynecol. 2016;127:289-96.
    PubMed     Text format     Abstract available


  44. RAYMOND EG, Weaver MA, Tan YL, Louie KS, et al
    Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016;127:306-12.
    PubMed     Text format     Abstract available


    December 2015
  45. D'ALTON ME
    Every Woman, Every Time: Opportunity for Improvement.
    Obstet Gynecol. 2015;126:1133-5.
    PubMed     Text format    


    November 2015
  46. CHAMPALOUX SW, Tepper NK, Curtis KM, Zapata LB, et al
    Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  47. LEMAIRE WJ
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  48. ESPEY E
    In Reply.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  49. CHEN MJ, Creinin MD
    In Reply.
    Obstet Gynecol. 2015;126:1107-8.
    PubMed     Text format    


  50. BLUMENTHAL PD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:1107.
    PubMed     Text format    



  51. ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.
    Obstet Gynecol. 2015;126:e100-7.
    PubMed     Text format     Abstract available


  52. CHEN MJ, Creinin MD
    Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp.
    Obstet Gynecol. 2015;126:935-8.
    PubMed     Text format     Abstract available


  53. GILLIAM ML
    Beyond Coercion: Let Us Grapple With Bias.
    Obstet Gynecol. 2015;126:915-6.
    PubMed     Text format    


    October 2015
  54. KAKAIRE O, Byamugisha JK, Tumwesigye NM, Gemzell-Danielsson K, et al
    Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  55. KAVANAUGH ML, Jerman J, Finer LB
    Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  56. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:e44-8.
    PubMed     Text format     Abstract available



  57. Committee Opinion No. 642 Summary: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:912.
    PubMed     Text format     Abstract available


    September 2015
  58. CHANG K, Merideth MA, Stratton P
    Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  59. ABRAHAM M, Zhao Q, Peipert JF
    Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  60. Practice Bulletin No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:e1-e11.
    PubMed     Text format     Abstract available



  61. Practice Bulletin Summary No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:685-6.
    PubMed     Text format     Abstract available


    August 2015
  62. ESPEY E
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:396-400.
    PubMed     Text format     Abstract available


  63. LINDLEY KJ, Madden T, Cahill AG, Ludbrook PA, et al
    Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease.
    Obstet Gynecol. 2015;126:363-9.
    PubMed     Text format     Abstract available


  64. BIGGS MA, Harper CC, Brindis CD
    California Family Planning Health Care Providers' Challenges to Same-Day Long-Acting Reversible Contraception Provision.
    Obstet Gynecol. 2015;126:338-45.
    PubMed     Text format     Abstract available


    July 2015
  65. GOLDBERG AB, Fortin JA, Drey EA, Dean G, et al
    Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  66. GUIAHI M, McBride M, Sheeder J, Teal S, et al
    Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  67. DOMINICK SA, McLean MR, Whitcomb BW, Gorman JR, et al
    Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  68. HOPKINS MR, Laughlin-Tommaso SK, Wall DJ, Breitkopf DM, et al
    Hysterosalpingography After Radiofrequency Endometrial Ablation and Hysteroscopic Sterilization as a Concomitant Procedure.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  69. DIVASTA AD, Feldman HA, Sadler Gallagher J, Stokes NA, et al
    Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  70. GARIEPY AM, Duffy JY, Xu X
    Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Obstet Gynecol. 2015;126:47-55.
    PubMed     Text format     Abstract available


  71. CHEN MJ, Creinin MD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:12-21.
    PubMed     Text format     Abstract available


  72. DALTON VK, Wallett S
    The Evolution of Medication Abortion Care: Using Science to Achieve Quality.
    Obstet Gynecol. 2015;126:3-4.
    PubMed     Text format    


    June 2015
  73. WHITE K, Teal SB, Potter JE
    Contraception after delivery and short interpregnancy intervals among women in the United States.
    Obstet Gynecol. 2015;125:1471-7.
    PubMed     Text format     Abstract available


    May 2015
  74. LEKOVICH JP, Amrane S, Pangasa M, Pereira N, et al
    Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices.
    Obstet Gynecol. 2015;125:1101-5.
    PubMed     Text format     Abstract available


    March 2015
  75. MCNICHOLAS C, Maddipati R, Zhao Q, Swor E, et al
    Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the u.s. Food and drug administration-approved duration.
    Obstet Gynecol. 2015;125:599-604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: